Xtant Medical names new chief officer: 4 highlights

Xtant Medical appointed Kevin Brandt as chief commercial officer, effective July 9.

Advertisement

Here are four highlights:

1. Mr. Brandt brings more than 28 years of medical device industry experience into his new role.

2. He formerly served as executive president and CCO for RTI Surgical’s domestic direct business.

3. Prior to working at RTI Surgical, Mr. Brant spent 18 years with Stryker.

4. At Stryker, Mr. Brandt served in various leadership positions, including president of osteokinetics for 10 years.

“We are excited to have such a talented and experienced executive officer join our team,” said Carl O’Connell, CEO of Xtant. “[Mr. Brandt’s] past accomplishments in the medical device industry show that he is an accomplished business strategist with a unique ability to provide the leadership in sales and marketing to build our Company’s revenues and profitability. I expect his contributions will be transformative for Xtant.”

More articles on devices and implants:
More than just outcomes — Predictive analytics provide support through the surgical continuum
Moving from art to science brings new possibilities to spine surgery
Globus Medical, SeaSpine & more: 5 device company notes

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.